Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gregory, NC
Brandon Glenn Gregory, Lillington, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20090276712 | Safety awareness system - The disclosure describes, in one aspect, a method of providing notification data. A user can input notification data at a terminal in response to one or more prompts. The notification data is transmitted from the terminal to a centralized server. The centralized server stores the notification data. The centralized server may be polled to obtain the notification data stored by the centralized server. Finally, notification display systems display a visual indication of the notification data. | 11-05-2009 |
Christopher W. Gregory, Cary, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20080214639 | Leuprolide acetate and acetylcholinesterase inhibitors/NMDA receptor antagonists for the treatment of alzheimer's disease - Methods of treating, mitigating, slowing the progression of, or preventing Alzheimer's Disease include administration of gonadotropin-releasing hormone analogues in combination with acetylcholinesterase inhibitors and/or N-methyl-D-aspartate receptor antagonists. | 09-04-2008 |
| 20090197796 | Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors - Methods are provided for treating HPG axis-positive cancers, preventing or slowing proliferation of cells of HPG axis-positive cancer origin, preventing HPG axis-positive cancers in a patient at risk of contracting such cancers, preventing or inhibiting an upregulation of the cell cycle in HPG axis-positive cancer-derived cells in a patient, and decreasing the level of HPG axis-positive cancer-specific markers in a patient. | 08-06-2009 |
| 20110195898 | TREATMENT OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT USING GNRH-I ANALOGS AND ONE OR MORE OF ACETYLCHOLINESTERASE INHIBITORS AND NMDA RECEPTOR ANTAGONISTS - Methods of treating, mitigating, slowing the progression of, or preventing Alzheimer's Disease and Mild Cognitive Impairment (MCI) include administration of gonadotropin-releasing hormone analogs in combination with acetylcholinesterase inhibitors and/or N-methyl-D-aspartate receptor antagonists. | 08-11-2011 |
| 20110286998 | METHODS FOR TREATING AND PREVENTING CANCERS THAT EXPRESS THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS OF HORMONES AND RECEPTORS - Methods are provided for treating HPG axis-positive cancers, preventing or slowing proliferation of cells of HPG axis-positive cancer origin, preventing HPG axis-positive cancers in a patient at risk of contracting such cancers, preventing or inhibiting an upregulation of the cell cycle in HPG axis-positive cancer-derived cells in a patient, and decreasing the level of HPG axis-positive cancer-specific markers in a patient. | 11-24-2011 |
Daniel Constantine Gregory, Chapel Hill, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20100145532 | DISTRIBUTED HYBRID RENEWABLE ENERGY POWER PLANT AND METHODS, SYSTEMS, AND COMPTUER READABLE MEDIA FOR CONTROLLING A DISTRIBUTED HYBRID RENEWABLE ENERGY POWER PLANT - The subject matter described herein includes a distributed hybrid renewable energy power plant. One exemplary hybrid renewable energy power plant includes a plurality of renewable energy power generation sources that are distributed over a geographic area. A plurality of grid interface boxes connect each of the renewable energy power generation sources to a power distribution grid, measure power output by each of the renewable energy power generation sources, and regulate power delivered to the grid by each of the renewable energy power generation sources. A plant front end communicates with the grid interface boxes, determines a total output power available from the renewable energy power generation sources based on instantaneous power available from each of the renewable energy power generation sources, determines a statistical availability of the total output power based on weather and other conditions affecting power output from the renewable energy power generation sources, and outputs the total output power and the statistical availability to an energy management system. | 06-10-2010 |
James T. Gregory, Charlotte, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20120006833 | SHOWER NICHE KIT - A shower niche kit includes: at least one bottle and a shaving cream container sleeve. The at least one bottle is adapted to receive a liquid soap, a shampoo, or a conditioner. The shaving cream container sleeve is adapted to fit around and conceal a shaving cream container. The at least one bottle and the sleeve may have a similar pattern or design on them. | 01-12-2012 |
Kristin S. Gregory, Charlotte, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20120006833 | SHOWER NICHE KIT - A shower niche kit includes: at least one bottle and a shaving cream container sleeve. The at least one bottle is adapted to receive a liquid soap, a shampoo, or a conditioner. The shaving cream container sleeve is adapted to fit around and conceal a shaving cream container. The at least one bottle and the sleeve may have a similar pattern or design on them. | 01-12-2012 |
Michael Gregory, Huntersville, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20090166307 | STORAGE SYSTEM - A storage system comprises a rail having a protrusion including a first flange and a second flange. An accessory mount for mounting to the rail includes a top hook for engaging the first flange and a resilient bottom hook for engaging the second flange. The rail comprises a back rail portion comprising a substantially planar member and a front rail portion substantially coextensive with the back rail portion and secured to the back rail portion. The protrusion may be symmetrical about the longitudinal axis. The first flange and the second flange define first and second recesses. A method of assembling a support is also provided where a first hook is inserted the first flange and a second hook deforms to engage the second flange. | 07-02-2009 |
Owen Gregory, Apex, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20100116549 | High Voltage Electrical Cable Assembly - An electrical cable includes a core having a conductor, insulation surrounding the conductor, and an outer sheath surrounding the core. A portion of the conductor is stripped bare at a free end and a cavity is formed within the insulation at the cable free end. First and second shims are concentrically secured to the exposed portion of the conductor such that end portions of the shims are positioned adjacent to the cavity. The bare conductor is secured within a barrel portion of a terminal lug. A first sealing mastic material is disposed within the cavity and heated to encapsulate end portions of the shims. A second sealing mastic material is applied around the lug barrel portion, first and second shims, and a portion of the outer sheath. A heat shrinkable tube having an inner surface of zinc oxide stress control mastic material is secured around the second sealing mastic material. | 05-13-2010 |
| 20100155212 | ISOLATING APPARATUS FOR ELECTRIC POWER LINES AND METHODS FOR FORMING AND USING THE SAME - An isolating apparatus for an electric power line includes an elongate insulator having opposed insulator ends and a pair of electrically conductive end members each secured to a respective one of the insulator ends. At least one of the end members includes a mounting slot that receives its respective one of the insulator ends. | 06-24-2010 |
| 20100314232 | CABLE TERMINATION SYSTEMS AND ISOLATING APPARATUS FOR ELECTRICAL POWER TRANSMISSION CONDUCTORS AND METHODS USING THE SAME - A conductor termination system for use with an electrical power transmission conductor includes a termination assembly and a connector. The termination assembly includes an end member and an integral retainer mechanism. The end member includes a receiver portion configured to receive a segment of the conductor. The retainer mechanism includes a moveable keeper member on the end member. The retainer mechanism is operable to selectively clamp a segment of the conductor in the receiver portion to the end member and to apply a retention load to the conductor segment. The connector is adapted to be applied to the end member and the conductor to securely clamp the conductor segment to the end member. | 12-16-2010 |
Simon Gregory, Durham, NC US
Simon G. Gregory, Durham, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20090035778 | METHODS AND COMPOSITIONS FOR CORRELATING GENETIC MARKERS WITH MULTIPLE SCLEROSIS - The present invention provides, in certain aspects, a method of identifying a subject as having an increased risk of developing multiple sclerosis, comprising detecting in the subject the presence of a nucleotide variant in the interleukin 7 receptor alpha chain gene, whereby the presence of said variant identifies the subject as having an increased risk of developing multiple sclerosis. | 02-05-2009 |
| 20090087844 | METHODS AND COMPOSITIONS FOR CORRELATING GENETIC MARKERS WITH CARDIOVASCULAR DISEASE - The present invention provides methods of identifying a subject having an increased or decreased risk of developing cardiovascular disease, comprising: | 04-02-2009 |
| 20110171630 | METHODS AND COMPOSITIONS FOR CORRELATING GENETIC MARKERS WITH CARDIOVASCULAR DISEASE - The present invention provides methods of identifying a subject having an increased or decreased risk of developing cardiovascular disease, comprising: a) correlating the presence of one or more genetic markers in chromosome 3q13.31 with an increased or decreased risk of developing cardiovascular disease; and b) detecting the one or more genetic markers of step (a) in the subject, thereby identifying the subject as having an increased or decreased risk of developing cardiovascular disease. Also provided are methods of identifying subjects with cardiovascular disease as having a good or poor prognosis, as well as methods of identifying effective treatment regimens for cardiovascular disease, based on correlation with genetic markers in chromosome 3q13.31. | 07-14-2011 |